Delivery Order SPE2DB22D2009-SPE2DB24FL9ET
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order, valued at $18,952.56, is for the supply of Bupropion HCL XL 150 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on this order, with no indicated set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,262,033 units of Bupropion HCL XL 150 mg tablets. The $10,933.71 contract has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide...
This is a $23,858.03 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,296,807 units of Bupropion HCL XL 150 mg tablets with a completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,925,239 tablets of Bupropion HCL XL 150 mg. The $27,015.60 contract has an ultimate completion date of March 12, 2024 and does not use any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 4563692636 - BUPROPION HCL XL 150 MG TABLET 500S. The order has a potential value of $19,253.37 and a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4,563,618,722 Bupropion HCL XL 300 mg tablets in quantities of 500 per bottle. The $20,759.83 delivery order has a completion date of February 12, 2024 and was awarded on February 9, 2024. This award is part of a larger indefinite delivery contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,489,505 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,327,324 units of Bupropion HCL XL 150 mg tablets. The contract has a firm fixed price of $58,443.58 and a period of performance through April 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment programs and facilities globally...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 500 units of Bupropion HCL XL 150 mg tablets, with a potential value of $12,963.91 and a completion date of February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a...